Alex Blyth - CEO LifT Biosciences at BIO Boston 2025 episode artwork

EPISODE · Jul 22, 2025 · 15 MIN

Alex Blyth - CEO LifT Biosciences at BIO Boston 2025

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

From BIO Boston: Alex Blyth, CEO of LifT BiosciencesIn this powerful opening episode from BIO 2025, I sit down with Alex Blyth, the founder and CEO of LifT Biosciences — a company re-engineering the immune system to finally beat cancer at its own game.We talk about:Why targeted therapies are failing most patientsWhat tumour escape is and why it’s the real enemyHow LiFt’s “super neutrophils” could be the Keytruda of innate immunityAnd the personal loss that pushed Alex to rethink everything we know about cancer treatmentAlex’s story is sharp, ambitious, and deeply personal — exactly the kind of leadership biotech needs right now.This is the first in a series of in-person interviews from BIO Boston with some of the sharpest founders and execs in the industry. Stay tuned — more to come.

NOW PLAYING

Alex Blyth - CEO LifT Biosciences at BIO Boston 2025

0:00 15:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 15 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on July 22, 2025.

What is this episode about?

From BIO Boston: Alex Blyth, CEO of LifT BiosciencesIn this powerful opening episode from BIO 2025, I sit down with Alex Blyth, the founder and CEO of LifT Biosciences — a company re-engineering the immune system to finally beat cancer at its own...

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!